Center-Authored Papers

Filters: Author is Kim, Dong-Wan  [Clear All Filters]
J
Jänne PA, Ou S-HI, Kim D-W, Oxnard GR, Martins R, Kris MG, Dunphy F, Nishio M, O'Connell J, Paweletz C et al..  2014.  Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial.. The Lancet. Oncology. 15(13):1433-41. Abstract
K
Kim D-W, Mehra R, Tan DSW, Felip E, Chow LQM, Camidge RD, Vansteenkiste J, Sharma S, De Pas T, Riely GJ et al..  2016.  Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.. The Lancet. Oncology. Abstract
S
Shaw AT, Kim D-W, Mehra R, Tan DSW, Felip E, Chow LQM, Camidge RD, Vansteenkiste J, Sharma S, De Pas T et al..  2014.  Ceritinib in ALK-rearranged non-small-cell lung cancer.. The New England journal of medicine. 370(13):1189-97. Abstract